Sawai Group Holdings (TSE:4887) recently issued earnings guidance for the fiscal year ending March 31, 2027, alongside first quarter 2026 results. These paired updates provide fresh insight into expectations and current performance.
See our latest analysis for Sawai Group Holdings.
The latest guidance and first quarter update arrive after a tougher share price period for Sawai Group Holdings, with the share price return down 31.99% year to date and the 1 year total shareholder return declining 14.52%. However, the 3 year total shareholder return is up 17.22% and the 5 year total shareholder return is up 11.59%, which points to longer term holders still being ahead despite more recent pressure on sentiment.
If you are weighing Sawai Group Holdings against other ideas in your portfolio, this can be a good moment to broaden your search and check out 12 top founder-led companies
Bulls can point to Sawai Group Holdings' guidance and valuation gap, while bears focus on the recent share price slide and weaker quarterly earnings. Which side does the current valuation actually support next?
On a headline basis, Sawai Group Holdings trades on a P/E of 19.5x, which screens as expensive compared with both industry and peer averages.
The P/E ratio compares the current share price to earnings per share. For a pharmaceutical company like Sawai Group Holdings, it reflects what investors are currently willing to pay for each unit of earnings, taking into account factors such as growth expectations, earnings quality and balance sheet strength.
In this case, the signals are mixed. Sawai Group Holdings is flagged as good value when its 19.5x P/E is compared with an estimated fair P/E of 21.9x, which points to some potential upside if the market moves closer to that level. At the same time, the stock is described as expensive on a straightforward comparison with the JP Pharmaceuticals industry average of 15x and a peer average of 14.2x, which suggests the market is assigning a premium multiple despite issues such as lower profit margins, one off items and weaker recent earnings.
Relative to its sector, the 19.5x P/E looks meaningfully higher than both the 15x industry average and the 14.2x peer group level. If the estimated fair P/E of 21.9x is used as a reference point, the market multiple could shift towards that figure over time, but there is no certainty this will occur.
Explore the SWS fair ratio for Sawai Group Holdings
Result: Price-to-Earnings of 19.5x (OVERVALUED).
However, Sawai Group Holdings still faces risks if weaker quarterly earnings persist or if the continued slide in its share price further pressures market confidence in its valuation.
Find out about the key risks to this Sawai Group Holdings narrative.
The P/E of 19.5x makes Sawai Group Holdings look expensive on simple earnings comparisons. Our DCF model tells a different story. At ¥1,609 the stock trades below an estimated future cash flow value of ¥2,591.48, which points to a sizeable implied discount. Could the P/E be missing something here?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Sawai Group Holdings for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 26 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
With Sawai Group Holdings sending mixed signals on valuation and sentiment, this is a good time to review the full picture yourself quickly. To weigh both the downside concerns and the potential upside, take a closer look at the 2 key rewards and 4 important warning signs
If Sawai Group Holdings has you thinking harder about portfolio quality, use this moment to line up your next potential opportunities before the crowd moves on.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com